Wearable Suicidal Early Warning System for Adolescents

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Jun 1, 2026 to Feb 1, 2027
    • Publications: details revised at 2 of 2 entries
    • Eligibility criteria expanded, about 3 words
  2. Minor Re-verified, no change to tracked fieldsv11
  3. Notable Primary completion date changed from estimate of Jul 1, 2023 to Jun 30, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Oct 1, 2023 to Jun 1, 2026
    • Site details revised
    v10
  4. Notable Primary completion date: Jul 1, 2022 to Jul 1, 2023
    • Study completion date: Oct 1, 2022 to Oct 1, 2023
    v9
  5. Notable Primary completion date: Jan 1, 2021 to Jul 1, 2022
    • Study completion date: Jul 1, 2021 to Oct 1, 2022
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Notable Enrollment target: 100 to 250v7 Show 4 more changesShow less
    • Primary completion date: Jul 3, 2020 to Jan 1, 2021
    • Study completion date: Jul 3, 2020 to Jul 1, 2021
    • Study description shortened, about 8 words
    • Collaborators: 1 to 2
  2. Notable Primary and study completion dates: Jul 3, 2019 to Jul 3, 2020v6
  3. Minor Re-verified, no change to tracked fieldsv5
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 3, 2017 to Sep 18, 2017
    v4
  5. Notable Start date: May 1, 2017 to Jul 3, 2017
    • Primary endpoint revised
    • Primary and study completion dates: May 1, 2019 to Jul 3, 2019
    • Study title expanded, about 4 words
    v3
  6. Notable Primary endpoint revised
    • Secondary endpoints expanded, about 10 words
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.
Trial Details
NCT Number NCT03030924
Lead Sponsor Oregon Health and Science University
Collaborators: National Institute of Mental Health (NIMH), National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Suicide, Adolescent Behavior
Related terms Adolescent Behavior, Suicide
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov